WHO recommends second malaria vaccine, hoping to address supply issues
Just two years after the WHO’s historic recommendation of the first malaria vaccine, the global health agency on Monday recommended a second.
Just two years after the World Health Organization’s historic recommendation of the first malaria vaccine, the global health agency on Monday recommended a second, seeking to broaden access to a tool it hopes can save lives.
The vaccine, called R21/Matrix-M, was developed by the University of Oxford and will be produced by the Serum Institute of India, the world’s largest vaccine manufacturer.
What's Your Reaction?
